Welcome to our dedicated page for ESM news (Ticker: ESM), a resource for investors and traders seeking the latest updates and insights on ESM stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ESM's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ESM's position in the market.
ESM Acquisition Corporation (NYSE: ESM) announced the redemption of all outstanding ordinary shares effective March 10, 2023, due to the failure to complete a business combination by March 12, 2023. According to the Articles of Association, the company will cease operations and redeem public shares at approximately $10.20 per share. Shares will stop trading on March 9, 2023, and will be canceled post-redemption. The company plans to file a Form 25 with the SEC to delist its securities and subsequently file a Form 15 to terminate the registration of its securities. The initial stockholders waived their redemption rights regarding common stock issued prior to the IPO.
FAQ
What is the market cap of ESM (ESM)?
